July 1, 2021

House Resolution 841 aims to ensure that the Food and Drug Administration recognizes CBD products as dietary supplements. In Pharmacy Times, Ned Milenkovich, chair of Much’s Health Care group, shares how the bill may affect pharmacies, consumers, and the marketplace at large. 

This article contains material of general interest and should not be construed as legal advice or a legal opinion on any specific facts or circumstances. Under applicable rules of professional conduct, this content may be regarded as attorney advertising.